The estimated annual incidence of oral squamous cell carcinoma (OSCC) is approximately 275,000 new cases worldwide. OSCC is the eighth most prevalent cancer in the world [1]. In Taiwan, OSCC ranks fifth among the predominant cancers for both sexes and accounts for the fourth most common cancer for males [2]. Development of recurrent cancer and second primary cancer is one of the major causes of the poor 5-year overall survival of OSCC patients [3]. Therefore, it is crucial to find a biomarker that can predict the progression, recurrence, and prognosis of OSCC at its earliest stage.
http://ift.tt/2kBhgzq
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου